CryoLife, Inc. (CRY) Sets 1-Year High

May 16, 2018 - By Kristin Houston

CryoLife, Inc. (NYSE:CRY) Corporate Logo

Big Money Sentiment decreased to 1.33 in 2017 Q4. It has change of 0.26, from 2017Q3’s 1.59. The ratio fall due to CryoLife, Inc. positioning: 14 sold and 29 reduced. 13 funds bought stakes and 44 increased stakes. Investors holded 23.69 million in 2017Q3 but now own 24.23 million shares or 2.29% more.
Jpmorgan Chase Com reported 0% in CryoLife, Inc. (NYSE:CRY). Barclays Plc holds 0% or 11,296 shs in its capital. Renaissance Technologies Limited Liability Corp reported 668,100 shs or 0.01% of all its holdings. 7,834 are held by Citigroup Inc. Financial Bank Of Mellon Corporation has invested 0% in CryoLife, Inc. (NYSE:CRY). Texas Permanent School Fund has 22,608 shs. Northern Tru reported 0.01% in CryoLife, Inc. (NYSE:CRY). Teachers Retirement Systems Of The State Of Kentucky reported 3,600 shs. State Board Of Administration Of Florida Retirement invested in 29,527 shs or 0% of the stock. Teacher Retirement Of Texas has 10,268 shs. Arizona State Retirement Systems invested in 56,215 shs or 0.01% of the stock. 2,325 were reported by Tower Capital Lc (Trc). Schwab Charles Inv Mgmt invested in 0% or 178,618 shs. 74,850 are held by Next Century Growth Investors Ltd Com. Stratos Wealth Ltd invested 0% of its capital in CryoLife, Inc. (NYSE:CRY).

CryoLife, Inc. registered $1.13 million net activity with 0 insider purchases and 11 selling transactions since December 15, 2017. On Thursday, March 8 McCall Ronald D had sold 5,000 shs worth $105,448. On Thursday, May 3 Shares for $80,016 were sold by Davis John E. On Friday, December 15 the insider RONALD C ELKINS sold $20,000. 4,000 shs were sold by Horton Amy, worth $103,764.

By hitting $25.95 stock price a new 1-year high was recored by CryoLife, Inc. (NYSE:CRY). It was published on May, 16 by Barchart.com. The company has $950.61M market cap. The company’s valuation will be $85.55 million more at $28.29 PT.

CRY is reaching $25.95 during the last trading session, after increased 1.37%.CryoLife, Inc. is uptrending after having risen 19.34% since May 16, 2017. CRY has 261,457 volume or 106.91% up from normal. The stock outperformed the S&P500 by 7.79%.

Investors expect CryoLife, Inc. (NYSE:CRY)’s quarterly earnings on July, 23., Faxor reports. This year’s EPS analyst estimate is expected to be $-0.01. That is 108.33 % down compareed to $0.12 EPS for last year. Wall Street now predicts -150.00 % negative EPS growth despite CryoLife, Inc. last quarter’s EPS of $0.02.

Another two news for CryoLife, Inc. (NYSE:CRY) were recently published by: Streetinsider.com on May 02, 2018 with title “CryoLife (CRY) Reports In-Line Q1 EPS”. The other Seekingalpha.com‘s article was titled “CryoLife’s (CRY) CEO Pat Mackin on Q1 2018 Results – Earnings Call Transcript” and published on May 06, 2018.

CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide.The firm is valued at $950.61 million. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries.The P/E ratio is 242.52. The firm operates in two divisions, Medical Devices and Preservation Services.

CryoLife, Inc. (NYSE:CRY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.